Build the complete record
Reports, scans, sequencing, pathology, treatment history, response, timing, and physician notes are brought into one private workspace.
For complex cancer cases
When standard of care is not enough, LightWay takes on the hard casework. We review the record, analyze tumor biology, and help the patient and oncologist pursue supported treatment routes.
Human review. Evidence tied to the record. Doctor-led decisions.
Our process
Patients and families should not have to become cancer researchers while also trying to make treatment decisions. LightWay builds the working record, performs maximal analysis of the tumor biology, develops and prioritizes treatment options, prepares the supporting evidence, helps pursue access to those options, and keeps the plan current as new results arrive.
Reports, scans, sequencing, pathology, treatment history, response, timing, and physician notes are brought into one private workspace.
We do maximal analysis of the available tumor biology to find relevant targets, immune signals, tissue checks, and treatment implications.
Standard of care, trials, targeted and off-label drugs, vaccines, international options, and treatment access routes are compared by evidence, timing, and feasibility.
We work with the patient, family, oncologist, trial sites, manufacturers, and regulatory pathways to move the selected routes forward.
New scans, blood tests, treatment response, trial changes, review dates, and open questions are tracked against the existing plan.
Inside the work
The work is not just a report. LightWay keeps the record, evidence, treatment options, access steps, and open questions together so the next decision has a clear basis.
A complex case can include pathology, scans, surgery, sequencing, immune markers, published studies, trial rules, tissue availability, and timing. LightWay keeps those details close to the conclusion they support instead of burying them in a long document.
Diagnosis, current disease state, prior treatment, response, available tissue, and test results.
Targets, mutations, expression, immune signals, and checks that could open or close a route.
Published studies, approvals, trial results, and case reports are separated from the patient's own facts.
Trial outreach, physician questions, manufacturer contacts, regulatory routes, and practical timing.
What we do
We begin with the current standard options, then extend the search across trials, targeted and off-label drugs, personalized vaccines, international care, and special approval routes. Every route stays tied to the patient's record and the evidence behind it.
We connect approved treatments to the diagnosis, prior therapy, current disease state, and tumor biology.
We match biology, diagnosis, prior therapy, location, eligibility, and timing, then help prepare the outreach.
We connect tumor findings to possible drugs, check what supports or weakens the rationale, and identify any tissue confirmation needed.
When the biology supports it, we examine peptide or mRNA vaccine routes, immune response, manufacturing, and timing.
We review treatments and trials elsewhere when the evidence and practical requirements make them relevant.
We help assemble the rationale, evidence, contacts, and physician-facing packet needed for a manufacturer or regulatory request.
Getting treatment access
LightWay does not stop after identifying an option. We help pursue access through eligibility review, outreach, medical rationale, source evidence, physician-facing material, and the appropriate trial, manufacturer, or regulatory route.
Current status, prioritized options, supporting evidence, unresolved questions, and the action each route requires.
Which studies are worth contacting, what records they need, and what might make the patient eligible or ineligible.
For drugs outside the usual route, we help assemble the medical rationale and supporting evidence.
When appropriate, we help prepare the evidence a physician would need for a regulatory access discussion.
Treatment and access routes
The first job is to understand the case. After that, the work branches: standard of care, a trial, a personalized vaccine, a targeted or off-label drug, an international option, or a regulatory access path may each require different work.
Reports, scans, pathology, sequencing, prior treatments, response, and open questions.
What is happening now, what is targetable, what has already been tried, and what evidence is still needed.
Put approved treatments in context with the tumor biology, prior therapy, and current disease state.
Match diagnosis, markers, prior therapy, timing, and location.
Evaluate peptide or mRNA options when the tumor biology supports it.
Connect the tumor finding to the drug, evidence, tissue checks, and clinical context.
Identify relevant treatments or trials and what travel, timing, and records would be required.
Prepare the evidence a physician, manufacturer, or regulator may need for an expanded or single-patient pathway.
The patient and oncologist can see what is possible now, what is being prepared, and what still needs to happen.
The exact route depends on the patient, the tumor, prior treatment, available tissue, location, timing, and physician review.
LightWay Hub
As new results come in, LightWay keeps your current status, next steps, treatment options, preparation, and supporting evidence together for the patient and the care team.
Disease state, recent changes, overdue follow-ups, and the next action.
Pathology, surgery, imaging, labs, sequencing, notes, and literature remain traceable.
What makes this tumor specific, what may be targetable, and what needs confirmation.
What is available now, what requires an access request, and what needs more evidence.
Biopsies, stains, trial packets, physician questions, and treatment request materials.
Surveillance timing, milestones, trial changes, review dates, and open questions.
For the family around the patient
Families often become the record keeper, trial researcher, appointment planner, and second-opinion coordinator. LightWay brings everything together and gives the family a team to analyze the case, prepare the next steps, and stay involved as things change.
Current status, recent changes, overdue follow-ups, and the next action are kept in one view.
New scans, labs, pathology, or sequencing are compared with the prior record and the existing plan.
Treatment options, tissue checks, trial work, treatment request packets, and backup paths remain visible before they are needed.
We gather the rationale, source evidence, contacts, and physician-facing material, then help coordinate the route with the care team.